ENSG Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31

cash flows from operating activities:
net income	83,911,000	84,466,000	80,353,000	79,750,000	78,567,000	71,181,000	68,960,000	21,823,000	63,968,000	64,090,000	59,969,000	60,519,000	56,242,000	57,803,000	50,088,000	50,583,000	49,837,000	46,162,000	43,312,000	40,689,000	41,201,000	27,326,000	27,828,000	28,925,000	27,607,000	26,559,000	20,350,000	22,326,000	23,293,000	11,222,000	14,274,000	12,381,000	2,956,000	21,006,000	11,184,000	11,363,000	9,290,000	14,437,000	13,157,000	13,235,000	15,088,000	10,796,000	8,371,000	1,533,000	13,041,000	10,612,000	12,404,000	-12,511,000	13,036,000	12,279,000	12,828,000	10,355,000	11,598,000	12,976,000	12,746,000	9,887,000	9,619,000	9,348,000	8,693,000	7,686,000	8,184,000	7,923,000	7,859,000	6,797,000	6,519,000	6,334,000	6,229,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	26,633,000	25,785,000	24,188,000	22,519,000	21,474,000	20,488,000	19,657,000	19,233,000	18,446,000	17,596,000	17,112,000	16,880,000	15,941,000	14,858,000	14,676,000	13,795,000	13,659,000	13,489,000	13,757,000	13,605,000	13,720,000	10,953,000	14,319,000	13,184,000	12,598,000	12,199,000	11,902,000	11,621,000	11,622,000	11,760,000	11,448,000	10,750,000	10,514,000	9,701,000	10,912,000	9,771,000	8,298,000	7,926,000	7,289,000	6,379,000	6,517,000	5,087,000	4,677,000	7,804,000	8,862,000	8,797,000	8,668,000	7,764,000	7,179,000	7,042,000	6,924,000	6,502,000	6,179,000	5,546,000	5,059,000	4,260,000	4,023,000	3,955,000	3,863,000	3,239,000	3,209,000	2,965,000	2,517,000	2,353,000	2,178,000	1,993,000	1,965,000
amortization of deferred financing fees	263,000	264,000	266,000	265,000	265,000	265,000	266,000	265,000	266,000	267,000	269,000	266,000	265,000	282,000	223,000	210,000	210,000	210,000	210,000	210,000	210,000	214,000	293,000	290,000	293,000	293,000	294,000	289,000	299,000	272,000	258,000	255,000	254,000	254,000	258,000	159,000	154,000																						112,000	108,000	5,000	53,000	44,000	23,000	21,000	7,000
non-cash leasing arrangement	225,000	199,000	208,000	218,000	205,000	190,000	195,000	178,000	211,000	218,000	263,000	142,000	111,000	116,000	124,000	109,000	112,000	114,000	101,000	111,000	125,000	9,000	997,000
impairment of long-lived assets				0	0	0	1,849,000											0									0	705,000	155,000
deferred income taxes				-1,296,000	1,379,000	-86,000	638,000	-27,156,000	-372,000	0	47,000	-5,911,000	-849,000	0	264,000			-28,988,000	176,000	0	1,003,000					385,000	696,000	0	14,000	9,754,000	514,000	0	61,000	-1,551,000	-660,000	-18,000	21,000	473,000	762,000	-6,000	22,000	-2,600,000	33,000	-560,000	17,000	-673,000	26,000	-121,000	721,000	-2,250,000	1,653,000	2,933,000	11,000	-2,148,000	294,000	-1,571,000	-2,425,000	-715,000	560,000	-29,000	-2,268,000	1,026,000	-1,024,000	1,385,000	-213,000	-227,000
benefit from doubtful accounts	637,000	434,000	438,000	320,000	701,000	340,000	378,000	327,000	831,000	363,000	1,887,000	89,000	132,000	27,000	2,142,000	-661,000	2,560,000	2,865,000	2,634,000	247,000	1,312,000	990,000	299,000	540,000	615,000	722,000	1,129,000	402,000	570,000	9,089,000	7,287,000	7,297,000	7,350,000	8,442,000	7,989,000	6,316,000	5,765,000	6,032,000	5,302,000	3,725,000	4,743,000	3,908,000	2,637,000	3,229,000	3,405,000	2,978,000	2,554,000	2,973,000	2,256,000	2,127,000	1,812,000	1,939,000	1,941,000	1,814,000	2,227,000	1,485,000	1,398,000	1,550,000	1,606,000	920,000	817,000	1,213,000	163,000	1,000,000	999,000	1,051,000	996,000
stock-based compensation	12,989,000	11,662,000	10,724,000	9,820,000	9,184,000	8,984,000	8,238,000	8,076,000	7,237,000	8,881,000	6,573,000	6,039,000	5,898,000	5,616,000	5,167,000	4,633,000	4,054,000	3,588,000	4,173,000	3,528,000	3,235,000																														831,000	742,000	937,000	846,000	831,000	875,000	617,000	649,000	555,000	783,000	475,000	517,000	353,000	577,000	290,000	462,000	261,000
cash received from insurance proceeds	2,877,000			0	0	0	199,000	0	646,000
(gain) loss on insurance claims, other investments and asset disposals
change in operating assets and liabilities
accounts receivable	-35,331,000	5,564,000	-14,589,000	-15,372,000	-6,212,000	-27,849,000	-34,964,000	-13,188,000	-27,197,000	-2,297,000	-37,136,000	-54,874,000	-14,700,000	1,265,000	-14,117,000	-479,000	-15,449,000	-9,270,000	6,076,000	27,210,000	-21,845,000	-26,251,000	-11,457,000	-6,375,000	-16,341,000	-16,578,000	-9,997,000	7,023,000	6,453,000	-19,203,000	-18,809,000	-7,389,000	-6,900,000	-20,410,000	-13,912,000	-15,385,000	-13,910,000	-24,635,000	-25,954,000	-12,835,000	-36,900,000	-13,312,000	1,157,000	-7,108,000	-12,604,000	2,030,000	-11,705,000	-7,071,000	-3,875,000	-4,531,000	-9,532,000	-7,285,000	-5,210,000	-3,036,000	-9,264,000	-890,000	-4,704,000	-8,316,000	-12,292,000	704,000	651,000	-7,037,000	-4,754,000	-642,000	4,396,000	-786,000
prepaid income taxes	-9,054,000	-23,510,000	13,057,000	12,903,000	-7,162,000	-18,798,000	3,830,000	-3,829,000	457,000	-457,000	4,643,000	10,655,000	1,038,000	-16,336,000	5,452,000	-8,814,000	1,224,000	12,326,000	-13,550,000	0	739,000	1,419,000	3,952,000	-5,843,000	6,072,000	290,000	2,081,000	-6,797,000	6,654,000	-5,325,000	-3,779,000	-10,293,000	252,000	1,022,000	6,549,000	-4,619,000	4,887,000	-1,348,000	-2,073,000	-4,720,000	2,992,000	2,086,000	5,140,000	-7,579,000	7,250,000	-706,000	-2,329,000	-4,613,000	-616,000	-2,370,000	5,636,000	-2,025,000	-2,430,000	-1,427,000	1,333,000			1,242,000					2,195,000	-781,000	100,000	4,428,000
prepaid expenses and other assets	-7,247,000	8,891,000	-9,360,000	-2,387,000	-1,130,000	-4,150,000	-11,388,000	5,534,000	1,975,000	-3,960,000	3,444,000	-662,000	-4,483,000	-416,000	-3,580,000	-5,205,000	-4,271,000	-2,006,000	277,000	-2,444,000	-5,301,000	-10,944,000	365,000	-1,663,000	4,995,000	1,059,000	3,692,000	-5,616,000	2,162,000	-6,583,000	1,736,000	-1,743,000	-2,790,000	-1,512,000	-2,290,000	2,952,000	-615,000	-3,408,000	-3,023,000	-371,000	-3,538,000
cash surrender value of life insurance policy premiums	-4,037,000	-4,806,000	-7,489,000	7,000	-4,115,000	-1,047,000	-9,678,000	-4,349,000	409,000	-2,048,000	-10,084,000	-2,236,000	243,000	2,295,000	-7,916,000	-1,421,000	-7,440,000
deferred compensation liability	4,170,000	4,721,000	7,441,000	45,000	4,234,000	1,648,000	9,059,000	4,381,000	-507,000	2,344,000	9,826,000	2,266,000	-246,000	-2,184,000	7,801,000	1,471,000	7,459,000
operating lease obligations	-96,000	-3,067,000	-102,000	-44,000	-69,000	-206,000	606,000	-219,000	66,000	156,000	-6,567,000	130,000	762,000	-385,000	-162,000	2,000	-133,000	-182,000	-164,000	-197,000	-181,000	-4,131,000	-1,384,000
accounts payable	497,000	8,473,000	-3,521,000	8,072,000	322,000	4,817,000	-10,376,000	15,220,000	-316,000	-3,258,000	4,278,000	12,992,000	2,681,000	3,664,000	-1,467,000	4,957,000	2,768,000	-570,000	7,877,000	2,577,000	-3,257,000	8,674,000	-4,573,000	-202,000	558,000	1,051,000	2,105,000	6,741,000	-6,815,000	830,000	6,878,000	-335,000	-4,044,000	-1,578,000	1,610,000	2,036,000	-1,491,000	1,242,000	1,192,000	-5,047,000	4,393,000	3,814,000	431,000	904,000	2,829,000	2,381,000	-471,000	-4,860,000	2,044,000	5,494,000	-6,395,000	-1,515,000	3,867,000	-887,000	1,236,000	1,457,000	1,188,000	-419,000	2,624,000	-1,465,000	-833,000	2,490,000	415,000	-323,000	391,000	-2,500,000
accrued wages and related liabilities	45,072,000	42,498,000	-60,021,000	-5,311,000	33,646,000	30,635,000	-38,978,000	23,267,000	25,691,000	27,657,000	-28,648,000	24,675,000	19,469,000	23,827,000	-28,989,000	25,499,000	-34,562,000	35,345,000	22,102,000	20,535,000	-13,443,000	31,101,000	16,640,000	12,849,000	-13,204,000	20,608,000	9,586,000	5,444,000	-6,490,000	14,539,000	3,268,000	-2,575,000	-9,410,000	1,871,000	22,000	4,452,000	-11,323,000	13,415,000	6,993,000	3,874,000	-2,104,000	10,373,000	1,750,000	3,870,000	651,000	1,117,000	569,000	-1,905,000	942,000	361,000	-8,393,000	2,939,000	3,960,000	1,868,000	-4,186,000	3,297,000	170,000	-1,388,000	4,922,000	203,000	-1,732,000	-26,000	3,492,000	825,000	1,046,000	-1,115,000
other accrued liabilities	25,264,000	-6,461,000	8,278,000	-36,667,000	5,347,000	3,886,000	-3,236,000	12,441,000	11,965,000	235,000	-813,000	-2,153,000	12,634,000	-4,440,000	-3,031,000	-229,000	-1,737,000	-1,797,000	16,158,000	7,215,000	-4,040,000	-1,519,000	14,438,000	1,779,000	-3,345,000	-3,495,000	6,561,000	3,178,000	-647,000	-2,891,000	7,118,000	612,000	938,000	854,000	10,974,000	2,233,000	-1,473,000	3,466,000	9,946,000	1,434,000	6,557,000	-2,243,000	5,347,000	4,665,000	-1,432,000	2,899,000	-4,313,000	2,655,000	4,598,000	1,838,000	-1,583,000	2,989,000	3,271,000	226,000	-119,000	-173,000	-3,790,000	2,149,000	4,479,000	-637,000	-736,000	1,333,000	57,000	407,000	-397,000	-350,000
accrued self-insurance liabilities	353,000	13,854,000	8,710,000	26,633,000	-2,187,000	5,513,000	14,055,000	15,737,000	4,258,000	-537,000	9,369,000	5,817,000	-2,728,000	9,956,000	4,740,000	1,102,000	4,615,000	1,860,000	4,225,000	2,223,000	1,985,000	1,600,000	969,000	2,365,000	1,352,000	1,715,000	-1,324,000	4,288,000	1,061,000	639,000	1,697,000	2,191,000	1,568,000	-1,782,000	3,093,000	4,908,000	1,906,000	1,729,000	1,388,000	946,000	1,355,000
net cash from operating activities	153,000,000	155,730,000	72,220,000	100,456,000	134,481,000	76,937,000	35,312,000	85,269,000	123,315,000	119,738,000	48,344,000	50,176,000	92,524,000	83,939,000	45,874,000	74,103,000	34,294,000	91,190,000	108,023,000	147,015,000	27,123,000	54,630,000	65,315,000	47,436,000	24,842,000	53,025,000	56,037,000	60,845,000	40,395,000	9,703,000	38,329,000	5,334,000	19,586,000	2,704,000	34,356,000	24,133,000	12,695,000	20,069,000	6,492,000	948,000	5,860,000	18,193,000	29,611,000	15,644,000	21,432,000	30,503,000	4,925,000	21,682,000	26,533,000	19,742,000	5,318,000	19,442,000	25,799,000	8,757,000	18,689,000	19,557,000	4,578,000	10,325,000	17,588,000	9,983,000	8,294,000	10,406,000	11,072,000	11,014,000	15,109,000	9,476,000	7,660,000
capex	-51,193,000	-49,595,000	-42,926,000	-48,161,000	-45,444,000	-35,198,000	-29,437,000	-28,820,000	-25,746,000	-24,963,000	-26,651,000	-27,810,000	-22,653,000	-21,244,000	-15,838,000	-18,461,000	-15,334,000	-12,502,000	-10,754,000	-11,260,000	-15,810,000	-16,558,000	-19,221,000	-22,117,000	-13,645,000	-17,316,000	-13,337,000	-13,213,000	-11,082,000	-17,391,000	-16,762,000	-11,016,000	-11,997,000	-13,426,000	-15,830,000	-18,212,000	-18,231,000	-17,718,000	-13,526,000	-16,055,000	-12,719,000	-11,568,000	-9,548,000	-16,153,000	-16,424,000	-8,479,000	-8,189,000	-5,216,000	-10,373,000	-9,357,000	-7,025,000	-11,702,000	-10,387,000	-9,683,000	-9,001,000	-7,195,000	-7,338,000	-6,415,000	-5,466,000	-4,740,000	-6,747,000	-4,924,000	3,689,000	-4,358,000	-13,575,000	-5,578,000	0
free cash flows	101,807,000	106,135,000	29,294,000	52,295,000	89,037,000	41,739,000	5,875,000	56,449,000	97,569,000	94,775,000	21,693,000	22,366,000	69,871,000	62,695,000	30,036,000	55,642,000	18,960,000	78,688,000	97,269,000	135,755,000	11,313,000	38,072,000	46,094,000	25,319,000	11,197,000	35,709,000	42,700,000	47,632,000	29,313,000	-7,688,000	21,567,000	-5,682,000	7,589,000	-10,722,000	18,526,000	5,921,000	-5,536,000	2,351,000	-7,034,000	-15,107,000	-6,859,000	6,625,000	20,063,000	-509,000	5,008,000	22,024,000	-3,264,000	16,466,000	16,160,000	10,385,000	-1,707,000	7,740,000	15,412,000	-926,000	9,688,000	12,362,000	-2,760,000	3,910,000	12,122,000	5,243,000	1,547,000	5,482,000	14,761,000	6,656,000	1,534,000	3,898,000	7,660,000
cash flows from investing activities:
purchase of property and equipment	-51,193,000	-49,595,000	-42,926,000	-48,161,000	-45,444,000	-35,198,000	-29,437,000	-28,820,000	-25,746,000	-24,963,000	-26,651,000	-27,810,000	-22,653,000	-21,244,000	-15,838,000	-18,461,000	-15,334,000	-12,502,000	-10,754,000	-11,260,000	-15,810,000	-16,558,000	-19,221,000	-22,117,000	-13,645,000	-17,316,000	-13,337,000	-13,213,000	-11,082,000	-17,391,000	-16,762,000	-11,016,000	-11,997,000	-13,426,000	-15,830,000	-18,212,000	-18,231,000	-17,718,000	-13,526,000	-16,055,000	-12,719,000	-11,568,000	-9,548,000	-16,153,000	-16,424,000	-8,479,000	-8,189,000	-5,216,000	-10,373,000	-9,357,000	-7,025,000	-11,702,000	-10,387,000	-9,683,000	-9,001,000	-7,195,000	-7,338,000	-6,415,000	-5,466,000	-4,740,000	-6,747,000	-4,924,000	3,689,000	-4,358,000	-13,575,000	-5,578,000
cash payments for acquisitions	-35,691,000	-45,437,000	-159,172,000
escrow deposits		26,067,000	-35,069,000		-3,200,000	-160,000	-486,000	-891,000	877,000				7,284,000	-15,171,000	-400,000		-250,000	-65,000	329,000			-14,000,000			-300,000	-6,611,000	1,992,000	7,373,000	-10,025,000	621,000	23,076,000	-21,531,000	-2,394,000	-284,000	5,406,000	-5,058,000	-1,646,000	1,910,000	1,034,000	-859,000	-2,485,000	-15,553,000	1,280,000	1,372,000	-3,252,000	4,256,000	3,337,000	-7,843,000		2,730,000	-2,940,000		-8,268,000					-500,000	9,419,000
cash from insurance proceeds				1,772,000	601,000			900,000	216,000			196,000	490,000	222,000	431,000
cash proceeds from the sale of assets				10,000	820,000			200,000	30,000			4,000	961,000
purchases of investments	-29,113,000	-36,694,000	-25,984,000	-52,887,000	-16,754,000	-22,693,000	-12,815,000	-9,065,000	-2,113,000	-8,658,000	-9,767,000	-6,478,000	-11,979,000	-1,178,000	-2,340,000	-16,837,000	-6,869,000	-7,060,000	-8,664,000	-4,976,000	-1,008,000
maturities of investments	29,029,000	35,387,000	17,862,000	3,844,000	3,286,000	8,983,000	10,284,000	6,749,000	4,241,000	7,071,000	791,000	2,451,000	7,125,000	2,227,000	2,553,000	16,969,000	3,430,000	10,853,000	8,174,000	4,056,000	1,396,000
other restricted assets	-48,000	656,000	-9,000	-1,848,000	-216,000	-301,000	-300,000	97,000	461,000	769,000	-357,000	-24,000	-196,000	-395,000	764,000	120,000	-279,000	-340,000	-341,000	-358,000	-237,000
net cash from investing activities	-77,313,000	-68,120,000	-243,804,000	-166,587,000	-78,901,000	-109,909,000	-34,655,000	-44,944,000	-75,319,000	-26,464,000	-35,971,000	-42,411,000	-67,175,000	-28,356,000	-48,240,000	-28,650,000	-12,212,000	-10,181,000	-20,159,000	-12,784,000	-15,542,000	-97,627,000	-51,132,000	-72,863,000	-25,393,000	-55,942,000	-14,025,000	-55,781,000	-25,463,000	-23,527,000	-34,440,000	-27,229,000	-21,397,000	-98,212,000	-12,567,000	-79,753,000	-20,104,000	-47,962,000	-31,149,000	-52,972,000	-36,455,000	-73,444,000	-12,003,000	-59,319,000	-28,085,000	-10,155,000	-27,746,000	-19,145,000	-26,011,000	-17,509,000	-18,321,000	-29,182,000	-68,625,000	-19,026,000	-39,219,000	-7,605,000	-18,275,000	-6,878,000	-35,028,000	-21,369,000	-6,479,000	-17,593,000	-25,101,000	-4,455,000	-15,616,000	-5,758,000
cash flows from financing activities:
proceeds from debt				0								200,000	0
payments on debt	-1,025,000	-1,016,000	-1,009,000	-1,000,000	-1,392,000	-983,000	-975,000	-1,116,000	-959,000	-951,000	-1,007,000	-1,198,000	-987,000	-942,000	-979,000
issuance of common stock upon exercise of options	9,024,000	8,652,000	5,050,000	3,990,000	7,977,000	4,090,000	6,229,000	5,662,000	4,148,000	5,905,000	2,654,000	3,971,000	2,635,000	3,303,000	2,768,000	2,982,000	3,880,000	6,242,000	4,404,000	456,000	1,552,000	1,127,000	1,829,000	3,213,000	2,334,000		1,357,000	1,858,000	2,920,000	1,062,000	1,963,000	1,292,000	957,000	1,026,000	1,413,000	747,000	3,377,000	509,000	484,000	934,000	2,410,000	965,000	313,000	1,199,000	998,000	793,000	607,000	1,294,000	1,001,000	928,000	2,067,000	325,000	333,000	174,000	775,000	110,000	84,000	264,000	13,000	137,000	30,000	74,000	58,000	8,000	39,000	74,000	85,000
repurchase of shares of common stock to satisfy tax withholding obligations	0	-1,057,000	-14,000	0	0	-1,195,000	-14,000	0	0	-1,909,000	-20,000	0	0	-1,687,000	-15,000	-1,600,000	-9,000	-10,000	-154,000			0	0
repurchase of shares of common stock	0	-9,225,000	-10,775,000									0	0	-20,000,000	-9,882,000			0	0	0	-25,000,000									0	0	-1,220,000	-6,068,000	0	0	0	-30,000,000
dividends paid	-3,605,000	-3,597,000	-3,589,000	-3,437,000	-3,424,000	-3,414,000	-3,396,000	-3,243,000	-3,232,000	-3,214,000	-3,201,000	-3,050,000	-3,041,000	-3,042,000	-3,035,000	-2,886,000	-2,868,000	-2,724,000	-2,718,000	-2,683,000	-2,705,000	-2,564,000	-2,558,000	-2,543,000	-2,525,000	-2,377,000	-2,347,000	-2,367,000	-2,328,000	-2,189,000	-2,178,000	-2,171,000	-2,179,000	-2,042,000	-2,034,000	-2,025,000	-2,072,000	-1,935,000	-1,930,000	-1,921,000	-1,708,000	-1,544,000	-1,587,000	-1,602,000	-1,564,000	-1,438,000			-1,297,000	-1,293,000	-1,283,000	-1,169,000	-1,160,000	-1,158,000	-1,150,000	-1,039,000	-1,037,000	-1,032,000	-929,000	-926,000	-927,000	-925,000	-817,000	-822,000	-827,000	-819,000
non-controlling interest distribution				-265,000	0	0	-278,000	0	0	0	-4,000	-273,000	-3,000			-641,000	-1,248,000	-480,000	-1,243,000	-240,000	-720,000	-280,000	-177,000			-2,000	-44,000	0	-292,000
purchase of non-controlling interest	-382,000	-64,000	-11,000	0	-4,411,000	-29,000	-10,000	-22,000	-57,000	-100,000	-77,000	-9,000	-669,000	0	-26,000															0	0	0	-83,000
net cash from financing activities				-1,337,000	-850,000	-1,531,000	1,556,000	1,431,000	-100,000	-269,000	-1,674,000	-359,000	-2,065,000	-18,549,000	-11,289,000	-2,569,000	-103,117,000											-12,937,000	-22,212,000	16,106,000	2,690,000	23,864,000	-24,388,000	112,800,000	-14,894,000	37,769,000	17,210,000	29,393,000	14,091,000			66,453,000	-795,000	8,599,000	-1,633,000	-1,850,000	7,784,000	-686,000	-1,279,000	-2,066,000	16,037,000	13,674,000	30,365,000	-2,593,000	-585,000	-1,379,000	-1,402,000	-850,000	34,930,000	-936,000	-1,188,000	-1,079,000	-1,052,000	-1,086,000	-3,005,000	-1,004,000
net (decrease)/increase in cash and cash equivalents																42,884,000	-81,035,000
cash and cash equivalents beginning of period	0	0	464,598,000	0	0	0	509,626,000	0	0	0	316,270,000	0	0	0	262,201,000	0	236,562,000						0	0	31,083,000	0	0	0	42,337,000	0	0	0	57,706,000	0	0	0	41,569,000	0	0	0	50,408,000	0	0	0	65,755,000	0	0	40,685,000	0	0	29,584,000		0	0	72,088,000	0	0	38,855,000		0	0	41,326,000		0	0	51,732,000
cash and cash equivalents end of period	79,699,000	81,303,000	282,666,000	-67,468,000	54,730,000	-34,503,000	511,839,000	41,756,000	47,896,000	93,005,000	326,969,000	7,406,000	23,284,000	37,034,000	248,546,000	42,884,000	155,527,000	61,182,000	-26,358,000	138,521,000	63,217,000	14,779,000	5,354,000	1,218,000	37,824,000	-14,574,000	18,473,000	-7,873,000	35,057,000	2,282,000	6,579,000	1,969,000	31,507,000	17,292,000	6,895,000	-17,851,000	51,370,000	1,500,000	-10,566,000	-11,974,000	62,609,000	11,202,000	16,813,000	-35,076,000	57,469,000	18,498,000	-15,037,000	42,536,000	-757,000	167,000	32,618,000		-12,461,000	-12,862,000	50,973,000	10,573,000	-15,099,000	41,452,000		-12,322,000	627,000	33,060,000		5,473,000	-3,512,000	54,446,000
(gain) loss on insurance claims and asset disposals
litigation
cash from insurance proceeds and the sale of assets		1,496,000	1,494,000
net cash (used in)/provided by in financing activities		-6,307,000	-10,348,000
net decrease in cash and cash equivalents															-13,655,000													-7,873,000	-7,280,000		6,579,000							1,500,000															-12,461,000	-12,862,000	-21,115,000	10,573,000
gain on insurance claims and asset disposals			420,000
income taxes payable			13,219,000				16,173,000		15,541,000	11,390,000	13,850,000				10,416,000	-11,927,000	11,791,000			11,577,000	10,882,000				990,000					0	0	-2,357,000	1,175,000	936,000	246,000																				6,592,000
net increase in cash and cash equivalents			-181,932,000	-67,468,000	54,730,000	-34,503,000	2,213,000	41,756,000	47,896,000	93,005,000	10,699,000	7,406,000	23,284,000								4,042,000												-26,199,000			-17,851,000	9,801,000			-11,974,000	12,201,000	11,202,000			-8,286,000	18,498,000	-15,037,000	1,851,000	-757,000	167,000	3,034,000							2,597,000	17,490,000			-8,266,000	-15,081,000			2,174,000
write-off of deferred financing fees												0	0																					0
gain on sale of assets												0	-900,000
deferred employer portion of social security taxes
other long-term liabilities				311,000	-8,000			-13,000	-14,000			-12,000	-11,000	-12,000	-11,000	10,000	-167,000	-30,608,000	20,263,000	19,922,000	677,000
proceeds from sale of subsidiary shares												0	0										0			0
payment of contingent consideration
payments of deferred financing costs								0	0	0	-19,000	0	0	-3,077,000	-120,000											0	0	73,000	-91,000	-2,717,000				0	-1,893,000	0	-1,385,000					0	0			0	-12,000	-718,000	0	-39,000	-219,000	-28,000	-2,504,000	0	-39,000	0	-3,000	-5,000	-868,000	-25,000	-52,000	-25,000	0	-93,000	4,000	-296,000
gain on sale of assets and insurance claims
litigation adjustment					-555,000
cash payments for business acquisitions					0	0	-494,000					0	0	0	-16,400,000							18,758,000	-3,951,000	-13,258,000	-8,004,000	-3,100,000
cash payments for asset acquisitions					-17,994,000	-62,953,000	-1,943,000	-14,114,000	-53,285,000			-19,037,000	-48,207,000	-482,000	-17,010,000			-1,920,000	-9,023,000	0	-14,054,000	-66,269,000	-32,150,000	-37,413,000	-5,763,000	-27,455,000	-2,313,000	-51,099,000	-4,447,000
(gain)/loss on insurance claims, legal matters and asset disposals							-171,000
cash proceeds from insurance proceeds and the sale of assets							536,000
deconsolidation of an ancillary business
cash payments for medicare and medicaid licenses
proceeds from cares act provider relief fund and medicare advance payment program																		10,979,000
repayments of cares act provider relief fund and medicare advance payment program																-2,399,000	-111,162,000	-32,944,000
(gain)/loss on insurance claims, legal adjustments and asset disposals									-246,000
loss on insurance claims, legal finding and asset disposals											62,000		1,025,000
cash proceeds from the sale of assets and insurance proceeds											13,000							853,000	120,000	118,000	121,000	216,000	5,260,000	54,000	2,521,000			1,546,000	64,000
gain on insurance claims, legal finding and asset disposals
escrow deposits used to fund acquisitions																		0	0	0	14,050,000	0	0	0	7,271,000	0	0	0	228,000
loss/(gain) on insurance claims, legal finding and asset disposals															4,054,000
loss on sale of asset disposals
cash proceeds from insurance proceeds																455,000	6,250,000
cash proceeds from the sale of assets and ancillary business																37,000	840,000
proceeds from revolving credit facility and other debt																		36,600,000	0	120,600,000	260,000,000	485,000,000	360,000,000	270,000,000	265,000,000	245,000,000	195,000,000	210,000,000	195,000,000
payments on revolving credit facility and other debt																-648,000	-849,000	-37,490,000	-30,857,000	-320,732,000	-240,666,000	-433,160,000	-362,529,000	-243,448,000	-257,517,000	-257,512,000	-217,505,000	-222,501,000	-217,421,000	-322,065,000	-217,037,000	-89,037,000	-362,015,000	-212,033,000	-200,165,000	-137,164,000	-110,152,000	-80,150,000	-80,149,000	-60,091,000	-94,027,000
(gain)/loss on sale of asset disposals																	-236,000
proceeds from cares act provider relief fund																	9,139,000
net income from discontinued operations, net of tax
amortization of deferred gain on sale-leaseback																										-165,000	-164,000	-165,000	-164,000	-165,000	-164,000
cash received from insurance proceeds related to reconstruction of damaged properties and business interruptions
loss/(gain) on insurance claims and disposal of assets
income tax refund																										0	0
deferred employer portion of social security taxes under cares act
net cash from continuing operating activities																		91,190,000	108,023,000	147,015,000	27,123,000
net cash from discontinued operating activities
net cash from continuing investing activities																		-10,181,000	-20,159,000	-12,784,000	-15,542,000
net cash from discontinued investing activities
dividends received from pennant
cash retained by pennant at spin-off
net cash (used in)/provided by continuing financing activities																		-19,827,000	-114,222,000	4,290,000	-7,539,000
net cash from discontinued financing activities
net cash (used in)/provided by financing activities																		-19,827,000	-114,222,000	4,290,000	-7,539,000					-11,657,000
net increase/(decrease) in cash and cash equivalents																								1,218,000	6,741,000
cash and cash equivalents beginning of period, including cash of discontinued operations																		0	0	0	59,175,000
cash and cash equivalents end of period, including cash of discontinued operations																		61,182,000	-26,358,000	138,521,000	63,217,000
less cash of discontinued operations at end of period
cash received from insurance proceeds related to replacement properties and business interruptions																			174,000			795,000	166,000			785,000
gain on insurance claims and disposal of assets
repurchase of shares of common stock and subsidiary shares																							-5,394,000			0
cares act provider relief funds
proceeds from medicare advance payment program
net increase in cash, cash equivalents, and restricted cash
loss on insurance claims and disposal of assets																					101,000
impairment of long-lived assets and goodwill																						2,673,000
share-based compensation																						2,089,000	2,978,000	3,302,000	2,953,000	2,698,000	2,810,000	2,520,000	2,309,000	2,940,000	2,155,000	2,376,000	2,224,000	2,194,000	2,242,000	2,780,000	1,885,000	1,729,000	1,722,000	1,733,000	1,493,000	1,377,000	1,430,000	1,204,000	1,179,000	987,000	954,000	991,000	869,000
(gain)/loss on insurance claims and disposal of assets
liabilities related to operational closures																														-410,000	0
cash proceeds from sale leaseback
net cash provided by/(used in) continuing financing activities
net cash provided by/(used in) financing activities																						57,776,000	-8,829,000	26,645,000	7,292,000
gains on insurance claims and disposal of assets																									-4,000
insurance subsidiary deposits																																																										-175,000	-230,000	-783,000	-1,102,000	50,000	-710,000	-700,000	-939,000	-586,000
other long-term liability																							991,000	1,315,000	-43,000
investments and change in other assets																							-1,020,000
amortization of right-of-use assets																									-254,000
change in other assets																									-7,473,000
excess tax benefit from share-based compensation																																		-829,000	-716,000	-849,000	-685,000	-889,000	-891,000	-1,259,000	-641,000	-1,861,000	-471,000	-1,244,000	-688,000	-593,000	-411,000	-497,000	-527,000
(loss)/gain on insurance claims and disposal of assets
gain on sale of urgent care centers																																		-16,655,000
deferred rent and other long-term liability
cash received from sale of urgent care centers and franchising businesses, net of note receivable
cash proceeds from sale-leaseback																														0	0
issuance of treasury stock upon exercise of options																																		0	14,000			71,000	0	10,000	6,000	195,000	4,000	77,000	94,000	4,000	2,000	34,000	239,000	27,000	120,000	618,000	518,000	2,000	103,000	14,000	27,000	132,000	65,000	105,000	17,000	23,000	3,000	45,000	16,000	194,000	179,000
issuance of common stock upon exercise of options and vesting of restricted stock
goodwill and intangibles asset impairment
insurance subsidiary deposits and investments																											2,172,000	-2,651,000	80,000	-6,423,000	4,189,000	-4,537,000	179,000	-19,000	-644,000	-1,563,000	1,759,000	-168,000	-9,941,000	-471,000	-205,000	121,000	-1,921,000	117,000	150,000	167,000	-349,000	196,000	174,000	-5,409,000	-416,000	-147,000	-344,000	-510,000	607,000	-448,000
charge related to class action lawsuit																															0	0	11,000,000
deferred rent liability																											-195,000	37,000	339,000	-168,000	330,000	79,000	242,000	751,000	78,000	45,000	82,000	-263,000	454,000	97,000	26,000	83,000	-10,000	-61,000	-14,000	14,000	-76,000	-198,000	-5,000	105,000	212,000	610,000	-391,000	-19,000	-289,000	53,000	-350,000	453,000	458,000	379,000	-117,000	-50,000	15,000	-354,000	-228,000	-46,000	-173,000
cash proceeds from the sale of assets and insurance proceeds related to damaged properties
restricted and other assets																											-103,000	-388,000	-201,000	-1,921,000	17,000	-139,000	-193,000	1,374,000	-386,000	-289,000	-334,000	-1,337,000	-1,273,000	186,000	-389,000	-216,000	-350,000	488,000	-262,000	-24,000	21,000	-177,000	-84,000	119,000	-1,517,000	-126,000	455,000	-211,000	-278,000	-160,000	-245,000	1,000		274,000	-177,000	-181,000				-180,000
insurance proceeds received for damage to property																													167,000
gain on insurance claims for damaged property and other assets																													-667,000
gain on disposition of intangibles, property and equipment
escrow deposits used to fund business acquisitions																														0	0	0	1,582,000	0	0	0	400,000	0	0	0	16,153,000	0	0	0	1,000,000	0	0	4,635,000	0	0	175,000	0	0	0	14,422,000	0	0	7,595,000	0	0	0	10,090,000
use of restricted cash																																						0	1,481,000	1,907,000	1,694,000
cash proceeds from the sale of fixed assets and insurance proceeds
proceeds from common stock offering																																						0	0	0	112,078,000
issuance costs in connection with common stock offering																																						0	-210,000	-147,000	-5,604,000
long-lived asset impairment																															0	0	111,000
gain on disposition of property and equipment																																																		194,000	9,000
cash payment for business acquisitions																															-42,300,000	-32,952,000	-8,693,000	-500,000	-7,729,000	-55,591,000	-490,000	-30,928,000	-18,867,000	-22,298,000	-38,709,000	-49,701,000	-4,526,000	-29,294,000	-9,148,000	-6,054,000	-28,664,000	-10,646,000	-4,512,000	-11,002,000	-7,043,000	-20,208,000	-41,510,000	-7,955,000	-37,074,000	0	-11,192,000	-7,617,000	-39,168,000	0	0	-22,133,000	0
cash payment for asset acquisitions																															0	0	-310,000	-120,158,000	0			-1,899,000	2,000			1,000	-426,000									-6,802,000	-9,244,000	0	-7,339,000
cash proceeds from the sale of property and equipment and insurance proceeds																															1,529,000	409,000	608,000	0	20,000	174,000	197,000
proceeds from revolving credit facility																															220,000,000	115,000,000	345,000,000	325,000,000	187,000,000	175,250,000	156,750,000	110,000,000	95,000,000
losses related to operational closures																																	3,906,000
fixed assets impairment																																		0	0	0	137,000
loss on extinguishment of debt																																										0	0									0
loss on termination of interest rate swap																																										0	0
(gain)/loss on disposition of property and equipment																																		185,000
increase in restricted cash
cash retained by caretrust at separation																																										0	0
prepayment penalty on early retirement of debt
losses related to operational closure																																			-177,000	-240,000	7,798,000
cash received from sale of urgent care centers, net of note receivable
write-off of deferred financing fee																																				0	197,000
income tax payable																																					13,000				5,914,000
income from sale of discontinued operations																																														0	13,000	2,824,000
goodwill and other indefinite-lived intangibles impairment
amortization of deferred financing fees and debt discount																																						148,000	147,000	148,000	148,000	148,000	148,000	186,000	205,000	205,000	205,000	206,000	209,000	208,000	203,000		191,000	159,000	168,000	159,000	136,000	191,000
gain on sale of equity method investment																																														0
loss on disposition of property and equipment																																						183,000				86,000	10,000			35,000	-14,000	1,143,000				69,000			-3,000	221,000	1,000	21,000	0	7,000	3,000	61,000	264,000	55,000	5,000	152,000	103,000
u.s. government inquiry accrual
cash proceeds on sale of urgent care franchising business, net of note receivable																																														0
cash proceeds on sale of equity method investment																																														0
cash proceeds from the sale of property and equipment																																										23,000	0	0	1,000	146,000	539,000	102,000	9,000	1,000	29,000
proceeds from from revolving credit facility																																									29,000,000
net cash provided (used) in financing activities																																									42,796,000
deferred income tax effect of purchase of noncontrolling interest
accrued self-insurance																																										319,000	1,634,000	1,561,000	-1,633,000	843,000	-1,972,000	1,681,000	546,000	3,629,000	1,621,000		1,216,000	429,000	1,396,000	506,000	1,908,000	1,481,000		1,199,000	2,462,000	326,000		-305,000	987,000	869,000
deposits of restricted cash
uses of restricted cash
proceeds from issuance of debt																																										95,000,000	60,000,000			0			0	0	21,525,000	15,000,000
prepayment penalties on early retirement of debt																																										0
prepaid expenses and other current assets																																											-752,000	1,390,000	215,000	-590,000	1,552,000	25,000	-1,073,000	461,000	306,000	608,000	-1,202,000	-399,000	502,000	-254,000	-832,000	632,000	1,578,000	-2,287,000	-715,000	-382,000	58,000	704,000	-31,000	-104,000
change in restricted cash
payments on long-term debt																																											-60,000,000	-239,322,000	-1,849,000	-1,802,000	-1,788,000	-1,793,000	-1,749,000
(gain) loss on disposition of property and equipment																																													-1,000
supplemental disclosures of cash flow information:
cash paid during the period for:
interest																																													3,369,000	3,197,000	3,173,000	3,094,000	3,091,000	3,033,000	3,096,000		5,001,000	2,712,000	2,900,000	2,351,000	2,304,000	2,222,000	1,470,000	1,251,000	1,213,000	1,344,000	1,262,000	1,126,000	1,161,000	1,239,000
income taxes																																													158,000	7,348,000	9,730,000	160,000	6,901,000				9,187,000	10,295,000	7,870,000	8,305,000	7,985,000	6,065,000	4,710,000	8,066,000	4,100,000	8,100,000	3,191,000	3,810,000	4,308,000	106,000
non-cash financing and investing activity:
accrued capital expenditures																																													1,793,000	249,000	-1,420,000	1,997,000	90,000	-1,020,000	1,829,000		-587,000	313,000	895,000
acquisition of redeemable noncontrolling interest																																																	0	0	11,600,000
note receivable on sale of urgent care franchising business																																														0
u.s. government inquiry settlement																																															0	33,000,000
repurchases of shares of common stock
excess tax benefit from share based compensation																																																			-398,000	-489,000	-459,000	-91,000	-441,000	-43,000	-24,000	-333,000	37,000	-44,000	-9,000	-56,000	21,000	-7,000	-15,000	-106,000
payments on long term debt																																																			-6,571,000	-1,561,000	-42,281,000	-1,702,000	-715,000	-507,000	-497,000	-542,000	-364,000	-263,000	-259,000	-275,000	-273,000	-231,000	-2,252,000	-263,000
goodwill impairment
impairment of software development costs																																																								-109,000
escrow deposits for acquisitions
cash proceeds from the sale of fixed assets																																																				113,000	329,000	273,000	51,000	0	0	58,000
principal payments under capital lease obligation
cash and cash equivalents beginning of year																																																																			0
cash and cash equivalents end of year																																																																			45,314,000
non-cash investing activity:
principal payments on capital lease obligations																																																												-8,000	-6,000	-7,000
restricted assets																																																															-154,000	-105,000
other assets																																																															-28,000	8,000
repurchase of common stock
proceeds from sale of common stock in connection with initial public offering (ipo), net of issuance costs
supplemental disclosures of cash flow information
non-cash investing and financing activities:
capital lease obligation
in conjunction with acquisitions:
fair value of assets acquired
less: debt assumed in connection with acquisitions
cash paid for acquisitions
purchase of other investments																																																														-445,000
purchase of treasury stock
capital lease obligations
transfer of capital reserves from other assets to property and equipment
conditional asset retirement obligations under fin 47
debt assumed in connection with acquisitions
payments of deferred offering costs
cash payment for acquisitions
employee notes

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.